Latest Breaking News On - Head of life sciences - Page 6 : vimarsana.com

ClavystBio launches to translate life sciences breakthroughs into health impact

/PRNewswire/ ClavystBio launches to translate life sciences breakthroughs into health impact

New yorkUnited statesNational university of singaporeSingapore generalRepublic ofRush universityCity ofUnited kingdomPrnewswire clavystbioVicki satoPatricia leeTemasek charterTate anzurFidah alsagoffWong kan sengAsia pacific

Ultragenyx Pharma (RARE) Sells Portion of Future North American Royalties on Crysvita for $500M to OMERS

Ultragenyx Pharma (RARE) Sells Portion of Future North American Royalties on Crysvita for $500M to OMERS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRob missereUltragenyx pharmaceutical incDavies ward phillips vinebergLatham watkinsKyowa kirin co ltdHead of life sciencesGibson dunnNorth americaMardi dierChief financial officerManaging directorLife sciencesDavies ward phillips

Investegate |Open Orphan PLC Announcements | Open Orphan PLC: Board appointment amendment

Investegate announcements from Open Orphan PLC, Board appointment amendment

United statesFrance generalUnited kingdomCity ofTower hamletsPaul mcmanus sam allenMartin john gouldstoneMartin gouldstoneAnthony farrellLouis ashe jepsonYamin mo khanPharmacopeia incNominations committeeAudit risk committeeOrthopaedic research united kingdomSempiternum ltd

Investegate |Open Orphan PLC Announcements | Open Orphan PLC: Board appointment

Investegate announcements from Open Orphan PLC, Board appointment

United statesFrance generalUnited kingdomCity ofTower hamletsPaul mcmanus sam allenMartin john gouldstoneMartin gouldstoneAnthony farrellLouis ashe jepsonYamin mo khanPharmacopeia incNominations committeeAudit risk committeeBusiness development at owkinOrthopaedic research united kingdom

Open Orphan appoints Martin Gouldstone as an Independent Non-Executive Director

Open Orphan appoints Martin Gouldstone as an Independent Non-Executive Director

United statesUnited kingdomMartin gouldstoneYamin mo khanPharmacopeia incNominations committeeAudit risk committeeBusiness development at owkinLicensing lead at confirmant ltdRemuneration committeeSareum ltdSensyne healthHead of life sciencesBusiness developmentOpen orphanIndependent non executive director